Designating an Orphan Product: Drugs and Biological Products
Aug 12, 2024 · The FDA has authority to grant orphan drug designation to a drug or biological product to prevent, diagnose or treat a rare disease or condition.
Search Orphan Drug Designations and Approvals - Food and Drug …
This page searches the Orphan Drug Product designation database. Searches may be run by entering the product name, orphan designation, and dates. Results can be displayed as a …
Orphan Drug Designation: Disease Considerations | FDA
For a complete list of orphan drug designations and approvals see the searchable Orphan Products Designation Database. FDA considers ovarian cancer, fallopian tube cancer, and …
Orphan drug - Wikipedia
According to the US Food and Drug Administration (FDA), an orphan drug is defined as one "intended for the treatment, prevention or diagnosis of a rare disease or condition, which is …
Frequently Asked Questions (FAQ) About Designating an Orphan …
In order to designate a product as an orphan drug, the scientific rationale portion of the designation application must include enough information to establish a medically plausible …
Orphan designation - European Medicines Agency (EMA)
To qualify for orphan designation, a medicine must meet a number of criteria: no satisfactory method of diagnosis, prevention or treatment of the condition concerned can be authorised, or, …
eCFR :: 21 CFR Part 316 -- Orphan Drugs
(10) Orphan drug means a drug intended for use in a rare disease or condition as defined in section 526 of the act. (11) Orphan-drug designation means FDA's act of granting a request …
Where is OOPD within FDA? The mission of OOPD is to advance the evaluation and development of products that demonstrate promise for the diagnosis and/or treatment of rare …
The ODA amends the Food, Drug, and Cosmetic Act (FDCA) to create two primary mechanisms to encourage orphan drug development: orphan-drug designation (described in 42 U.S.C. § …
Special FDA designations for drug development: orphan, fast …
Over the past decades, US Congress enabled the US Food and Drug Administration (FDA) to facilitate and expedite drug development for serious conditions filling unmet medical needs …